Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA038660-02
Application #
3176828
Study Section
Experimental Virology Study Section (EVR)
Project Start
1984-12-01
Project End
1986-04-30
Budget Start
1985-12-01
Budget End
1986-04-30
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
Organized Research Units
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Shapiro, D J; Sharp, P A; Wahli, W W et al. (1988) A high-efficiency HeLa cell nuclear transcription extract. DNA 7:47-55
Konarska, M M; Sharp, P A (1987) Interactions between small nuclear ribonucleoprotein particles in formation of spliceosomes. Cell 49:763-74
Baldwin Jr, A S; Sharp, P A (1987) Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene. Mol Cell Biol 7:305-13
Moore, C L; Skolnik-David, H; Sharp, P A (1986) Analysis of RNA cleavage at the adenovirus-2 L3 polyadenylation site. EMBO J 5:1929-38
Staudt, L M; Singh, H; Sen, R et al. (1986) A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature 323:640-3
Konarska, M M; Sharp, P A (1986) Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs. Cell 46:845-55
Samuels, M; Sharp, P A (1986) Purification and characterization of a specific RNA polymerase II transcription factor. J Biol Chem 261:2003-13
Singh, H; Sen, R; Baltimore, D et al. (1986) A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 319:154-8
Chodosh, L A; Carthew, R W; Sharp, P A (1986) A single polypeptide possesses the binding and transcription activities of the adenovirus major late transcription factor. Mol Cell Biol 6:4723-33
Weinberger, J; Baltimore, D; Sharp, P A (1986) Distinct factors bind to apparently homologous sequences in the immunoglobulin heavy-chain enhancer. Nature 322:846-8